Wong A - Search Results

1

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer.

Huang Y, Zhao JJ, Soon YY, Wong A, Aminkeng F, Ang Y, Asokumaran Y, Low JL, Lee M, Choo JRE, Chan G, Kee A, Tay SH, Goh BC, Soo RA. Huang Y, et al. Among authors: wong a. Thorac Cancer. 2022 Nov;13(22):3152-3161. doi: 10.1111/1759-7714.14667. Epub 2022 Sep 30. Thorac Cancer. 2022. PMID: 36177913 Free PMC article.

2

Evidence for disease control with erlotinib after gefitinib failure in typical gefitinib-sensitive Asian patients with non-small cell lung cancer.

Wong AS, Soong R, Seah SB, Lim SW, Chuah KL, Nga ME, Chin TM, Soo RA. Wong AS, et al. J Thorac Oncol. 2008 Apr;3(4):400-4. doi: 10.1097/JTO.0b013e318168c801. J Thorac Oncol. 2008. PMID: 18379359 Free article.

3

Lung cancer response to gefitinib, then erlotinib, then gefitinib again.

Wong AS, Seto KY, Chin TM, Soo RA. Wong AS, et al. J Thorac Oncol. 2008 Sep;3(9):1077-8. doi: 10.1097/JTO.0b013e318183afb0. J Thorac Oncol. 2008. PMID: 18758318 Free article. No abstract available.

4

Targeted therapy at the end of life for patients with lung cancer.

Wong AS, Teo C, Lim SW, Wong E, Soo RA, Chan N. Wong AS, et al. Among authors: wong e. J Palliat Med. 2010 Aug;13(8):945-8. doi: 10.1089/jpm.2010.0084. J Palliat Med. 2010. PMID: 20712464

5

How many adenocarcinoma lung cancers come from bronchioloalveolar carcinoma?

Wong AS, Seto KY, Ang B, Wong E, Chin TM, Nga ME, Soo RA. Wong AS, et al. Among authors: wong e. Thorac Cancer. 2011 May;2(2):54-60. doi: 10.1111/j.1759-7714.2011.00041.x. Thorac Cancer. 2011. PMID: 27755811 Free article.

6

Extremely low high-density lipoprotein cholesterol (HDL) in a patient with diffuse B-cell lymphoma.

Loh TP, Poon M, Chan GHJ, Sethi SK, Wong A. Loh TP, et al. Among authors: wong a. Pathology. 2017 Aug;49(5):550-551. doi: 10.1016/j.pathol.2017.03.011. Epub 2017 Jun 28. Pathology. 2017. PMID: 28666640 No abstract available.

7

Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancer.

Tsui DWY, Murtaza M, Wong ASC, Rueda OM, Smith CG, Chandrananda D, Soo RA, Lim HL, Goh BC, Caldas C, Forshew T, Gale D, Liu W, Morris J, Marass F, Eisen T, Chin TM, Rosenfeld N. Tsui DWY, et al. Among authors: wong asc. EMBO Mol Med. 2018 Jun;10(6):e7945. doi: 10.15252/emmm.201707945. EMBO Mol Med. 2018. PMID: 29848757 Free PMC article.

8

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.

Bandla A, Tan S, Kumarakulasinghe NB, Huang Y, Ang S, Magarajah G, Hairom Z, Lim JSJ, Wong A, Chan G, Ngoi N, Ang E, Lee YM, Chan A, Lee SC, Thakor N, Wilder-Smith E, Sundar R. Bandla A, et al. Among authors: wong a. Support Care Cancer. 2020 Aug;28(8):3691-3699. doi: 10.1007/s00520-019-05177-2. Epub 2019 Dec 6. Support Care Cancer. 2020. PMID: 31811482 Free PMC article.

9

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre.

Chan GH, Gwee YX, Low JL, Huang Y, Chan ZY, Choo JR, Ngoi NY, LE Ang Y, Muthu V, Chong WQ, Wong A, Soo RA. Chan GH, et al. Among authors: wong a. Lung Cancer. 2020 Aug;146:145-153. doi: 10.1016/j.lungcan.2020.05.020. Epub 2020 May 21. Lung Cancer. 2020. PMID: 32540557

10

Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.

Zhao JJ, Kumarakulasinghe NB, Muthu V, Lee M, Walsh R, Low JL, Choo J, Tan HL, Chong WQ, Ang Y, Chan G, Yong WP, Huang Y, Ngoi N, Wong A. Zhao JJ, et al. Among authors: wong a. Oncology. 2021;99(3):192-202. doi: 10.1159/000512000. Epub 2021 Jan 13. Oncology. 2021. PMID: 33440374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,365 results

Search Page